Rchr

J-GLOBAL ID：201501034461796564 Update date: Jul. 31, 2023

ASHIKARI Daisaku

アシカリダイサク | ASHIKARI Daisaku

Research field (1)： Urology

Research keywords (1)： Prostate cancer

Papers (5)：

Yamamoto S, Takayama KI, Obinata D, Fujiwara K, Ashikari D, Takahashi S, Inoue S. Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer. Cancer science. 2019. 110. 11. 3476-3485
Daisaku Ashikari, So Tawara, Katsuhiko Sato, Junichi Mochida, Shinobu Masuda, Kuniaki Mukai, Adina Turcu, Koshiro Nishimoto, Kenya Yamaguchi, Satoru Takahashi. Ectopic adrenal adenoma causing gross hematuria: Steroidogenic enzyme profiling and literature review. International Journal of Urology Case Reports. 2019. 2. 3. 158-161
D. Ashikari, K. Takayama, T. Tanaka, Y. Suzuki, D. Obinata, T. Fujimura, T. Urano, S. Takahashi, S. Inoue. Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer. Oncogene. 2017. 36. 45. 6272-6281
Daisaku Ashikari, Ken-Ichi Takayama, Daisuke Obinata, Satoru Takahashi, Satoshi Inoue. CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration. Cancer Science. 2017. 108. 7. 1386-1393
Yuta Yamada, Ken-Ichi Takayama, Tetsuya Fujimura, Daisaku Ashikari, Daisuke Obinata, Satoru Takahashi, Kazuhiro Ikeda, Shigenori Kakutani, Tomohiko Urano, Hiroshi Fukuhara, et al. A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor. Cancer Science. 2017. 108. 1. 32-41

Books (2)：

尿路結石のすべて
東京医学社 2020
Prostate cancer
Japanese Journal of Clinical Medicine 2016

Lectures and oral presentations (22)：

前立腺癌における新規AR応答遺伝子CLDN8の同定及び機能解析
(第108回日本泌尿器科学会総会 2020)
高齢者における腎部分切除術の検討
(第108回日本泌尿器科学会総会 2020)
他臓器浸潤を伴い集学的治療を要した進行性腎癌の一例
(第85回日本泌尿器科学会東部総会 2020)
後期高齢者における腎部分切除術の検討
(第33回日本老年泌尿器科学会 2020)
前立腺癌PDXモデルを応用した新規治療薬の探索.
(第57回日本癌治療学会学術集会 2019)

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM